Persistently adenovirus-infected lymphoid cells express microRNAs derived from the viral VAI and especially VAII RNA

Virology

Volumn 447, Issue 1-2, 2013, Pages 140-145

  Furuse, Yuki ^a   Ornelles, David A ^b   Cullen, Bryan R ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

Adenovirus; MicroRNAs; Persistent infection; RNA interference

Indexed keywords

MICRORNA; RNA INDUCED SILENCING COMPLEX; VIRUS RNA;

3' UNTRANSLATED REGION; 5' UNTRANSLATED REGION; ARTICLE; B LYMPHOCYTE; CELL CULTURE; CONTROLLED STUDY; GENE EXPRESSION; GENE MAPPING; HUMAN; HUMAN ADENOVIRUS; HUMAN CELL; IMMUNOPRECIPITATION; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RNA SEQUENCE; SEQUENCE ANALYSIS; T LYMPHOCYTE; VIRUS GENOME;

ADENOVIRUS; MICRORNAS; PERSISTENT INFECTION; RNA INTERFERENCE;

ADENOVIRUSES, HUMAN; CELL LINE; GENE SILENCING; HUMANS; LYMPHOCYTES; MICRORNAS; MODELS, MOLECULAR; NUCLEIC ACID CONFORMATION; RNA, VIRAL; VIRUS LATENCY;

EID: 84885157765     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2013.08.024     Document Type: Article

References (38)

1. Andersson M.G., Haasnoot P.C., Xu N., Berenjian S., Berkhout B., Akusjarvi G. Suppression of RNA interference by adenovirus virus-associated RNA. J. Virol. 2005, 79:9556-9565.
2. Aparicio O., Carnero E., Abad X., Razquin N., Guruceaga E., Segura V., Fortes P. Adenovirus VA RNA-derived miRNAs target cellular genes involved in cell growth, gene expression and DNA repair. Nucleic Acids Res. 2010, 38:750-763.
3. Aparicio O., Razquin N., Zaratiegui M., Narvaiza I., Fortes P. Adenovirus virus-associated RNA is processed to functional interfering RNAs involved in virus production. J. Virol. 2006, 80:1376-1384.
4. Avila M.M., Carballal G., Rovaletti H., Ebekian B., Cusminsky M., Weissenbacher M. Viral etiology in acute lower respiratory infections in children from a closed community. Am. Rev. Respir. Dis. 1989, 140:634-637.
5. Bartel D.P. MicroRNAs: target recognition and regulatory functions. Cell 2009, 136:215-233.
6. Bhat R.A., Domer P.H., Thimmappaya B. Structural requirements of adenovirus VAI RNA for its translation enhancement function. Mol. Cell. Biol. 1985, 5:187-196.
7. Bhat R.A., Thimmappaya B. Construction and analysis of additional adenovirus substitution mutants confirm the complementation of VAI RNA function by two small RNAs encoded by Epstein-Barr virus. J. Virol. 1985, 56:750-756.
8. Dölken L., Krmpotic A., Kothe S., Tuddenham L., Tanguy M., Marcinowski L., Ruzsics Z., Elefant N., Altuvia Y., Margalit H., Koszinowski U.H., Jonjic S., Pfeffer S. Cytomegalovirus microRNAs facilitate persistent virus infection in salivary glands. PLoS Pathog. 2010, 6:e1001150.
9. Edwards K.M., Thompson J., Paolini J., Wright P.F. Adenovirus infections in young children. Pediatrics 1985, 76:420-424.
10. Evans A.S. Latent adenovirus infections of the human respiratory tract. Am. J. Hyg. 1958, 67:256-266.
11. Fasold M., Langenberger D., Binder H., Stadler P.F., Hoffmann S. DARIO: a ncRNA detection and analysis tool for next-generation sequencing experiments. Nucleic Acids Res. 2011, 39:W112-117.
12. Fox J.P., Brandt C.D., Wassermann F.E., Hall C.E., Spigland I., Kogon A., Elveback L.R. The virus watch program: a continuing surveillance of viral infections in metropolitan New York families. VI. Observations of adenovirus infections: virus excretion patterns, antibody response, efficiency of surveillance, patterns of infections, and relation to illness. Am. J. Epidemiol. 1969, 89:25-50.
13. Fox J.P., Hall C.E., Cooney M.K. The Seattle Virus Watch. VII. Observations of adenovirus infections. Am. J. Epidemiol. 1977, 105:362-386.
14. Garnett C.T., Erdman D., Xu W., Gooding L.R. Prevalence and quantitation of species C adenovirus DNA in human mucosal lymphocytes. J. Virol. 2002, 76:10608-10616.
15. Garnett C.T., Talekar G., Mahr J.A., Huang W., Zhang Y., Ornelles D.A., Gooding L.R. Latent species C adenoviruses in human tonsil tissues. J. Virol. 2009, 83:2417-2428.
16. Kitajewski J., Schneider R.J., Safer B., Munemitsu S.M., Samuel C.E., Thimmappaya B., Shenk T. Adenovirus VAI RNA antagonizes the antiviral action of interferon by preventing activation of the interferon-induced eIF-2 alpha kinase. Cell 1986, 45:195-200.
17. Langmead B., Trapnell C., Pop M., Salzberg S.L. Ultrafast and memory-efficient alignment of short DNA sequences to the human genome. Genome Biol. 2009, 10:R25.
18. Lavery D., Fu S.M., Lufkin T., Chen-Kiang S. Productive infection of cultured human lymphoid cells by adenovirus. J. Virol. 1987, 61:1466-1472.
19. Li H., Handsaker B., Wysoker A., Fennell T., Ruan J., Homer N., Marth G., Abecasis G., Durbin R. The Sequence Alignment/Map format and SAMtools. Bioinformatics 2009, 25:2078-2079.
20. Lu S., Cullen B.R. Adenovirus VA1 noncoding RNA can inhibit small interfering RNA and MicroRNA biogenesis. J. Virol 2004, 78:12868-12876.
21. Ma Y., Mathews M.B. Comparative analysis of the structure and function of adenovirus virus-associated RNAs. J. Virol. 1993, 67:6605-6617.
22. Ma Y., Mathews M.B. Structure, function, and evolution of adenovirus-associated RNA: a phylogenetic approach. J. Virol. 1996, 70:5083-5099.
23. McNees A.L., Mahr J.A., Ornelles D., Gooding L.R. Postinternalization inhibition of adenovirus gene expression and infectious virus production in human T-cell lines. J. Virol. 2004, 78:6955-6966.
24. Murphy E., Vanicek J., Robins H., Shenk T., Levine A.J. Suppression of immediate-early viral gene expression by herpesvirus-coded microRNAs: implications for latency. Proc. Natl. Acad. Sci. USA 2008, 105:5453-5458.
25. Neumann R., Genersch E., Eggers H.J. Detection of adenovirus nucleic acid sequences in human tonsils in the absence of infectious virus. Virus. Res. 1987, 7:93-97.
26. O'Malley R.P., Duncan R.F., Hershey J.W., Mathews M.B. Modification of protein synthesis initiation factors and the shut-off of host protein synthesis in adenovirus-infected cells. Virology 1989, 168:112-118.
27. O'Malley R.P., Mariano T.M., Siekierka J., Mathews M.B. A mechanism for the control of protein synthesis by adenovirus VA RNAI. Cell 1986, 44:391-400.
28. Sano M., Kato Y., Taira K. Sequence-specific interference by small RNAs derived from adenovirus VAI RNA. FEBS Lett. 2006, 580:1553-1564.
29. Silver L., Anderson C.W. Interaction of human adenovirus serotype 2 with human lymphoid cells. Virology 1988, 165:377-387.
30. Skalsky R.L., Cullen B.R. Viruses, microRNAs, and host interactions. Ann. Rev. Microbiol. 2010, 64:123-141.
31. Söderlund H., Pettersson U., Vennstrom B., Philipson L., Mathews M.B. A new species of virus-coded low molecular weight RNA from cells infected with adenovirus type 2. Cell 1976, 7:585-593.
32. Thimmappaya B., Weinberger C., Schneider R.J., Shenk T. Adenovirus VAI RNA is required for efficient translation of viral mRNAs at late times after infection. Cell 1982, 31:543-551.
33. Tsutsumi A., Kawamata T., Izumi N., Seitz H., Tomari Y. Recognition of the pre-miRNA structure by Drosophila Dicer-1. Nat. Struct. Mol. Biol. 2011, 18:1153-1158.
34. Umbach J.L., Kramer M.F., Jurak I., Karnowski H.W., Coen D.M., Cullen B.R. MicroRNAs expressed by herpes simplex virus 1 during latent infection regulate viral mRNAs. Nature 2008, 454:780-783.
35. van der Veen J., Lambriex M. Relationship of adenovirus to lymphocytes in naturally infected human tonsils and adenoids. Infect. Immun. 1973, 7:604-609.
36. Wu G.J. Adenovirus DNA-directed transcription of 5.5S RNA in vitro. Proc. Natl. Acad. Sci. USA 1978, 75:2175-2179.
37. Xu N., Segerman B., Zhou X., Akusjarvi G. Adenovirus virus-associated RNAII-derived small RNAs are efficiently incorporated into the rna-induced silencing complex and associate with polyribosomes. J. Virol. 2007, 81:10540-10549.
38. Zhang Y., Huang W., Ornelles D.A., Gooding L.R. Modeling adenovirus latency in human lymphocyte cell lines. J. Virol 2010, 84:8799-8810.